trial · primary record
TheraSphere GBM
Glioblastoma Multiforme
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2027-06-30 |
| Primary endpoint | The number of grade 3-5 non-hematological toxicities |
| Registry ID | NCT05303467 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:05.564Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05303467
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.